Cessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokers

Drug and Alcohol Dependence

Volumn 163, Issue , 2016, Pages 157-164

  Gubner, Noah R ^a   Kozar Konieczna, Aleksandra ^b   Szoltysek Boldys, Izabela ^c   Slodczyk Mankowska, Ewa ^c   Goniewicz, Jerzy ^b   Sobczak, Andrzej ^c,d   Jacob, Peyton ^a   Benowitz, Neal L ^a,e   Goniewicz, Maciej L ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center of Addiction Treatment   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d INSTITUTE OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH   (Poland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Alcohol abuse; Alcoholism; Cigarettes; CYP2A6; Ethanol; Smoking; Tobacco

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; NICOTINE; NICOTINIC AGENT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DETOXIFICATION; FEMALE; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLITE; NICOTINE METABOLITE RATIO; NICOTINE REPLACEMENT THERAPY; OXIDATION KINETICS; POLAND; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TOTAL NICOTINE EQUIVALENT; URINALYSIS; DRINKING BEHAVIOR; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; PSYCHOLOGY; TOBACCO DEPENDENCE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL DRINKING; ALCOHOLISM; BIOMARKERS; FEMALE; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; POLAND; TOBACCO USE DISORDER;

EID: 84963978833     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.04.006     Document Type: Article

References (50)

1. Allen J.P., Litten R.Z., Strid N., Sillanaukee P. The role of biomarkers in alcoholism medication trials. Alcohol. Clin. Exp. Res. 2001, 25:1119-1125.
2. Altomare E., Leo M.A., Sato C., Vendemiale G., Lieber C.S. Interaction of ethanol with acetaminophen metabolism in the baboon. Biochem. Pharmacol. 1984, 33:2207-2212.
3. Aubin H., Tilikete S., Laureaux C., Nguyen Hac H., Roullet-Volmi M., Troupel S., Barrucand D. Smoking and coffee intake following alcohol withdrawal in alcoholic inpatients. Eur. Psychiatry 1995, 10:383-385.
4. Aubin H.J., Laureaux C., Tilikete S., Barrucand D. Changes in cigarette smoking and coffee drinking after alcohol detoxification in alcoholics. Addiction 1999, 94:411-416.
5. Benowitz N.L., Pomerleau O.F., Pomerleau C.S., Jacob P. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob. Res. 2003, 5:621-624.
6. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., Jacob P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther. 2006, 79:480-488.
7. Benowitz N.L., Hukkanen J., Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 2009, 192:29-60.
8. Benowitz N.L., Dains K.M., Dempsey D., Yu L., Jacob P., Jacob P. Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1160-1166.
9. Burling T.A., Ramsey T.G., Seidner A.L., Kondo C.S. Issues related to smoking cessation among substance abusers. J. Subst. Abuse 1997, 9:27-40.
10. Chenoweth M.J., Novalen M., Hawk L.W., Schnoll R.A., George T.P., Cinciripini P.M., Lerman C., Tyndale R.F. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol. Biomarkers Prev. 2014, 23:1773-1782.
11. Cook J.W., Fucito L.M., Piasecki T.M., Piper M.E., Schlam T.R., Berg K.M., Baker T.B. Relations of alcohol consumption with smoking cessation milestones and tobacco dependence. J. Consult. Clin. Psychol. 2012, 80:1075-1085.
12. Danaei G., Ding E.L., Mozaffarian D., Taylor B., Rehm J., Murray C.J., Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009, 6:e1000058.
13. Dempsey D., Jacob P., Benowitz N.L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J. Pharmacol. Exp. Ther. 2002, 301:594-598.
14. Dempsey D., Tutka P., Jacob P., Allen F., Schoedel K., Tyndale R.F., Benowitz N.L. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin. Pharmacol. Ther. 2004, 76:64-72.
15. Derby K.S., Cuthrell K., Caberto C., Carmella S.G., Franke A.A., Hecht S.S., Murphy S.E., Marchand L. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol. Biomarkers. Prev. 2008, 17:3526-3535.
16. Feng S., Kapur S., Sarkar M., Muhammad R., Mendes P., Newland K., Roethig H.J. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol. Lett. 2007, 173:101-106.
17. Ferguson C.S., Miksys S., Palmour R.M., Tyndale R.F. Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys. J. Pharmacol. Exp. Ther. 2012, 343:628-637.
18. Friend K.B., Pagano M.E. Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. J. Addict. Dis. 2005, 24:61-75.
19. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61:1107-1115.
20. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
21. Hesse L.M., He P., Krishnaswamy S., Hao Q., Hogan K., von Moltke L.L., Greenblatt D.J., Court M.H. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes. Pharmacogenetics 2004, 14:225-238.
22. Hughes J.R., Kalman D. Do smokers with alcohol problems have more difficulty quitting?. Drug Alcohol Depend. 2006, 82:91-102.
23. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 2005, 57:79-115.
24. Hurt R.D., Dale L.C., Offord K.P., Croghan I.T., Hays J.T., Gomez-Dahl L. Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction 1995, 90:1541-1546.
25. Jacob P., Yu L., Duan M., Ramos L., Yturralde O., Benowitz N.L. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J. Chromatogr B. Analyt. Technol. Biomed. Life Sci. 2011, 879:267-276.
26. Jin M., Arya P., Patel K., Singh B., Silverstein P.S., Bhat H.K., Kumar A., Kumar S. Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages. Alcohol. Clin. Exp. Res. 2011, 35:132-139.
27. Jin M., Earla R., Shah A., Earla R.L., Gupte R., Mitra A.K., Kumar A., Kumar S. A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. J. Neuroimmune Pharmacol. 2012, 7:289-299.
28. John U., Meyer C., Rumpf H.J., Hapke U. Probabilities of alcohol high-risk drinking, abuse or dependence estimated on grounds of tobacco smoking and nicotine dependence. Addiction 2003, 98:805-814.
29. John U., Meyer C., Rumpf H.J., Schumann A., Thyrian J.R., Hapke U. Strength of the relationship between tobacco smoking: nicotine dependence and the severity of alcohol dependence syndrome criteria in a population-based sample. Alcohol 2003, 38:606-612.
30. Keenan R.M., Hatsukami D.K., Pickens R.W., Gust S.W., Strelow L.J. The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and the natural environment. Psychopharmacology (Berl.) 1990, 100:77-83.
31. Lerman C., Tyndale R., Patterson F., Wileyto E.P., Shields P.G., Pinto A., Benowitz N. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin. Pharmacol. Ther. 2006, 79:600-608.
32. Lerman C., Schnoll R.A., Hawk L.W., Cinciripini P., George T.P., Wileyto E.P., Swan G.E., Benowitz N.L., Heitjan D.F., Tyndale R.F., PGRN-PNAT Research Group Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir. Med. 2015, 3:131-138.
33. Lu Y., Zhuge J., Wu D., Cederbaum A.I. Ethanol induction of CYP2A5: permissive role for CYP2E1. Drug Metab. Dispos. 2011, 39:330-336.
34. Lu Y., Zhang X.H., Cederbaum A.I. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. Toxicol. Sci. 2012, 128:427-438.
35. Marks J.L., Hill E.M., Pomerleau C.S., Mudd S.A., Blow F.C. Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. J. Subst. Abuse Treat. 1997, 14:521-527.
36. McKee S.A., Weinberger A.H. How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?. Annu. Rev. Clin. Psychol. 2013, 9:649-674.
37. Mwenifumbo J.C., Sellersm E.M., Tyndale R.F. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. Drug Alcohol Depend. 2007, 89:24-33.
38. Niemelä O., Parkkila S., Juvonen R.O., Viitala K., Gelboin H.V., Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J. Hepatol. 2000, 33:893-901.
39. Pérez-Stable E.J., Herrera B., Jacob I.P., Benowitz N.L. Nicotine metabolism and intake in black and white smokers. JAMA 1998, 280:152-156.
40. Ray R., Tyndale R.F., Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J. Neurogenet. 2009, 23:252-261.
41. Rubinstein M.L., Benowitz N.L., Auerback G.M., Moscicki A.B. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics 2008, 122:e643-647.
42. Scherer G., Engl J., Urban M., Gilch G., Janket D., Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 2007, 47:171-183.
43. Shiffman S., Dunbar M.S., Benowitz N.L. A comparison of nicotine biomarkers and smoking patterns in daily and nondaily smokers. Cancer Epidemiol. Biomarkers. Prev. 2014, 23:1264-1272.
44. Sofuoglu M., Herman A.I., Nadim H., Jatlow P. Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropsychopharmacology 2012, 37:1509-1516.
45. Strasser A.A., Benowitz N.L., Pinto A.G., Tang K.Z., Hecht S.S., Carmella S.G., Tyndale R.F., Lerman C.E. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol. Biomarkers Prev. 2011, 20:234-238.
46. Tanner J.A., Chenoweth M.J., Tyndale R.F. Pharmacogenetics of nicotine and associated smoking behaviors. Curr. Top. Behav. Neurosci. 2015, 23:37-86.
47. World Health Organization WHO, International Statistical Classification Of Diseases And Related Health Problems, 10th Revision (ICD-10). WHO Library Cataloguing-in-Publication Data. Geneva, Switzerland, 2010.
48. Xia X.Y., Peng R.X., Yu J.P., Wang H., Wang J. In vitro metabolic characteristics of cytochrome P-450 2A6 in Chinese liver microsomes. Acta Pharmacol. Sin. 2002, 23:471-476.
49. York J.L., Hirsch J.A. Drinking patterns and health status in smoking and nonsmoking alcoholics. Alcohol. Clin. Exp. Res. 1995, 19:666-673.
50. Zhu A.Z., Renner C.C., Hatsukami D.K., Swan G.E., Lerman C., Benowitz N.L., Tyndale R.F. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics race, and sex. Cancer Epidemiol. Biomarkers Prev. 2013, 22:708-718.